Therefore, DDR pathways make an ideal target for therapeutic intervention.33, 35, 55, 56 Our results demonstrated that SVA or ARO effectively inhibited activities of RB and other DDR checkpoint proteins in various tumor cells 72 h after treatments. The gene discussed is RB1; the disease is neoplasm.